Evidence map›Paper›PMID 22357630›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Francisella tularensis inhibits the intrinsic and extrinsic pathways to delay constitutive apoptosis and prolong human neutrophil lifespan.

Justin T Schwartz, Jason H Barker, Justin Kaufman, Drew C Fayram, Jenna M McCracken, Lee-Ann H Allen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 81 citations in OpenAlex.

  1. Trial
  2. Pathogens (Basel, Switzerland) · 2026
    Article
  3. Infection and immunity · 2026
    Article
  4. Neutrophil Killing ofJournal of innate immunity · 2026
    Article
  5. Frontiers in immunology · 2025
    Article
  6. Article
  7. TolC and EmrA1 contribute toJournal of bacteriology · 2024
    Article
  8. Article
  9. Microbes and the fate of neutrophils.Immunological reviews · 2023
    Review
  10. Article
  11. Frontiers in immunology · 2022
    Article
  12. Article
  13. Neutrophil Survival Signaling DuringFrontiers in cellular and infection microbiology · 2022
    Article
  14. Article
  15. Antioxidants & redox signaling · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Neutrophils in innate immunity and systems biology-level approaches.Wiley interdisciplinary reviews. Systems biology and medicine · 2020
    Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Justin T SchwartzInflammation Program, University of Iowa and the Veterans Administration Medical Center, Iowa City, IA 52242, USA.
Jason H Barker
Justin Kaufman
Drew C Fayram
Jenna M McCracken
Lee-Ann H Allen
Iowa City VA Medical Center · USUniversity of Iowa · US

Funding

Studies of the capsular-like antigen of F. tularensisP01AI044642 · NIAID · UNIVERSITY OF IOWA · PI ALLEN, LEE-ANN H · 1999 to 2014
$18.2M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007337 · NIGMS · UNIVERSITY OF IOWA · PI GEYER, PAMELA K., LENTZ, STEVEN R · 1985 to 2020
$15.9M
TRAINING IN MECHANISMS OF PARASITISMT32AI007511 · NIAID · UNIVERSITY OF IOWA · PI BUTLER, NOAH SULLIVAN, WEBER, MARY · 1996 to 2025
$8.1M
Inhibition of human neutrophil function by Francisella tularensisR01AI073835 · NIAID · UNIVERSITY OF IOWA · PI ALLEN, LEE-ANN H · 2008 to 2012
$1.9M
Human neutrophils, phospholipase A2 and S.aureus: microbial targets and responsesI01BX000513 · VA · IOWA CITY VA MEDICAL CENTER · PI NAUSEEF, WILLIAM M. · 2009 to 2017
–
BLRD VA I01 BX000513NIAID NIH HHS P01 AI044642NIAID NIH HHS P01AI044642NIAID NIH HHS R01 AI073835NIAID NIH HHS R01AI073835NIAID NIH HHS T32 AI007511NIAID NIH HHS T32AI007511NIGMS NIH HHS T32 GM007337
6 · The paper itself

Abstract

Francisella tularensis is a facultative intracellular bacterium that infects many cell types, including neutrophils. We demonstrated previously that F. tularensis inhibits NADPH oxidase assembly and activity and then escapes the phagosome to the cytosol, but effects on other aspects of neutrophil function are unknown. Neutrophils are short-lived cells that undergo constitutive apoptosis, and phagocytosis typically accelerates this process. We now demonstrate that F. tularensis significantly inhibited neutrophil apoptosis as indicated by morphologic analysis as well as annexin V and TUNEL staining. Thus, ∼80% of infected neutrophils remained viable at 48 h compared with ∼50% of control cells, and ∼40% of neutrophils that ingested opsonized zymosan. In keeping with this finding, processing and activation of procaspases-8, -9, and -3 were markedly diminished and delayed. F. tularensis also significantly impaired apoptosis triggered by Fas crosslinking. Of note, these effects were dose dependent and could be conferred by either intracellular or extracellular live bacteria, but not by formalin-killed organisms or isolated LPS and capsule, and were not affected by disruption of wbtA2 or FTT1236/FTL0708-genes required for LPS O-antigen and capsule biosynthesis. In summary, we demonstrate that F. tularensis profoundly impairs constitutive neutrophil apoptosis via effects on the intrinsic and extrinsic pathways, and thereby define a new aspect of innate immune evasion by this organism. As defects in neutrophil turnover prevent resolution of inflammation, our findings also suggest a mechanism that may in part account for the neutrophil accumulation, granuloma formation, and severe tissue damage that characterizes lethal pneumonic tularemia.

Indexed as

AdultAnnexin A5ApoptosisBacterial CapsulesCaspasesCysteine Proteinase InhibitorsDNA FragmentationEnzyme Activationfas ReceptorFrancisella tularensisHumansImmune EvasionIn Situ Nick-End LabelingInterleukin-8LipopolysaccharidesNeutrophilsAnnexin A5CaspasesCXCL8 protein, humanCysteine Proteinase Inhibitorsfas ReceptorInterleukin-8LipopolysaccharidesOpsonin ProteinsZymosan

Identifiers

PMID22357630
PMCPMC3311780
OpenAlexW1940802809

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.